FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2064403159> ?p ?o ?g. }

• W2064403159 abstract "Pituitary adenomas are associated with a variety of clinical manifestations resulting from excessive hormone secretion and tumor mass effects, and require a multidisciplinary management approach. This article discusses the treatment modalities for the management of patients with a prolactinoma, Cushing's disease and acromegaly, and summarizes the options for medical therapy in these patients. First-line treatment of prolactinomas is pharmacotherapy with dopamine agonists; recent reports of cardiac valve abnormalities associated with this class of medication in Parkinson's disease has prompted study in hyperprolactinemic populations. Patients with resistance to dopamine agonists may require other treatment. First-line treatment of Cushing's disease is pituitary surgery by a surgeon with experience in this condition. Current medical options for Cushing's disease block adrenal cortisol production, but do not treat the underlying disease. Pituitary-directed medical therapies are now being explored. In several small studies, the dopamine agonist cabergoline normalized urinary free cortisol in some patients. The multi-receptor targeted somatostatin analogue pasireotide (SOM230) shows promise as a pituitary-directed medical therapy in Cushing's disease; further studies will determine its efficacy and safety. Radiation therapy, with medical adrenal blockade while awaiting the effects of radiation, and bilateral adrenalectomy remain standard treatment options for patients not cured with pituitary surgery. In patients with acromegaly, surgery remains the first-line treatment option when the tumor is likely to be completely resected, or for debulking, especially when the tumor is compressing neurovisual structures. Primary therapy with somatostatin analogues has been used in some patients with large extrasellar tumors not amenable to surgical cure, patients at high surgical risk and patients who decline surgery. Pegvisomant is indicated in patients who have not responded to surgery and other medical therapy, although there are regional differences in when it is prescribed. In conclusion, the treatment of patients with pituitary adenomas requires a multidisciplinary approach. Dopamine agonists are an effective first-line medical therapy in most patients with a prolactinoma, and somatostatin analogues can be used as first-line therapy in selected patients with acromegaly. Current medical therapies for Cushing's disease primarily focus on adrenal blockade of cortisol production, although pasireotide and cabergoline show promise as pituitary-directed medical therapy for Cushing's disease; further long-term evaluation of efficacy and safety is important." @default.
• W2064403159 created "2016-06-24" @default.
• W2064403159 creator A5003544129 @default.
• W2064403159 creator A5048189170 @default.
• W2064403159 creator A5060580242 @default.
• W2064403159 creator A5067841207 @default.
• W2064403159 creator A5076292783 @default.
• W2064403159 date "2010-05-17" @default.
• W2064403159 modified "2023-10-14" @default.
• W2064403159 title "Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas" @default.
• W2064403159 cites W123434114 @default.
• W2064403159 cites W1487304702 @default.
• W2064403159 cites W1497341086 @default.
• W2064403159 cites W1595658925 @default.
• W2064403159 cites W1965221547 @default.
• W2064403159 cites W1973023724 @default.
• W2064403159 cites W1979748274 @default.
• W2064403159 cites W1983367273 @default.
• W2064403159 cites W1984025513 @default.
• W2064403159 cites W1984499153 @default.
• W2064403159 cites W1987858801 @default.
• W2064403159 cites W1988158211 @default.
• W2064403159 cites W1988641856 @default.
• W2064403159 cites W1988787595 @default.
• W2064403159 cites W1993320494 @default.
• W2064403159 cites W1997014156 @default.
• W2064403159 cites W1998673854 @default.
• W2064403159 cites W2000804718 @default.
• W2064403159 cites W2002337307 @default.
• W2064403159 cites W2005356839 @default.
• W2064403159 cites W2012451298 @default.
• W2064403159 cites W2014729851 @default.
• W2064403159 cites W2017283375 @default.
• W2064403159 cites W2022401782 @default.
• W2064403159 cites W2026489860 @default.
• W2064403159 cites W2028190688 @default.
• W2064403159 cites W2028805801 @default.
• W2064403159 cites W2033066182 @default.
• W2064403159 cites W2033505874 @default.
• W2064403159 cites W2034571118 @default.
• W2064403159 cites W2034841744 @default.
• W2064403159 cites W2039064285 @default.
• W2064403159 cites W2040743647 @default.
• W2064403159 cites W2045244724 @default.
• W2064403159 cites W2045311197 @default.
• W2064403159 cites W2045367123 @default.
• W2064403159 cites W2051408823 @default.
• W2064403159 cites W2055254907 @default.
• W2064403159 cites W2057835402 @default.
• W2064403159 cites W2058274628 @default.
• W2064403159 cites W2059251711 @default.
• W2064403159 cites W2061962280 @default.
• W2064403159 cites W2062122986 @default.
• W2064403159 cites W2063967949 @default.
• W2064403159 cites W2065213883 @default.
• W2064403159 cites W2065532093 @default.
• W2064403159 cites W2067084033 @default.
• W2064403159 cites W2067202852 @default.
• W2064403159 cites W2068704610 @default.
• W2064403159 cites W2069832931 @default.
• W2064403159 cites W2069875099 @default.
• W2064403159 cites W2071804899 @default.
• W2064403159 cites W2072860820 @default.
• W2064403159 cites W2079846716 @default.
• W2064403159 cites W2080232093 @default.
• W2064403159 cites W2083357304 @default.
• W2064403159 cites W2087322086 @default.
• W2064403159 cites W2087678619 @default.
• W2064403159 cites W2088031764 @default.
• W2064403159 cites W2092312381 @default.
• W2064403159 cites W2096923719 @default.
• W2064403159 cites W2099339964 @default.
• W2064403159 cites W2099447985 @default.
• W2064403159 cites W2100129802 @default.
• W2064403159 cites W2101569579 @default.
• W2064403159 cites W2103938643 @default.
• W2064403159 cites W2112309011 @default.
• W2064403159 cites W2116553454 @default.
• W2064403159 cites W2117731187 @default.
• W2064403159 cites W2118708995 @default.
• W2064403159 cites W2119094244 @default.
• W2064403159 cites W2120999525 @default.
• W2064403159 cites W2123601063 @default.
• W2064403159 cites W2127125241 @default.
• W2064403159 cites W2128035112 @default.
• W2064403159 cites W2131231109 @default.
• W2064403159 cites W2132094049 @default.
• W2064403159 cites W2136335235 @default.
• W2064403159 cites W2136781443 @default.
• W2064403159 cites W2138315222 @default.
• W2064403159 cites W2139926910 @default.
• W2064403159 cites W2140572454 @default.
• W2064403159 cites W2140741951 @default.
• W2064403159 cites W2142493227 @default.
• W2064403159 cites W2143194787 @default.
• W2064403159 cites W2143791513 @default.
• W2064403159 cites W2145600509 @default.
• W2064403159 cites W2145655269 @default.
• W2064403159 cites W2146245806 @default.
• W2064403159 cites W2147573461 @default.

• next